Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | RORB | Q92753 | 8/20 | 0.48 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.47 |
| ▸ | KDR | P35968 | 1/20 | 0.47 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.47 |
| ▸ | KMO | O15229 | 2/20 | 0.46 |
| ▸ | RORC | P51449 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | XDH | P47989 | 1/20 | 0.43 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.43 |
| ▸ | KIF11 | P52732 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Amflutizole SCHEMBL395613 | 1.00 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2RORBPDGFRBKDR | |
| SCHEMBL11000020 | 0.90 | KDR (0.53) | ALDH1A1SMN1; SMN2RORBPDGFRBKDR | |
| SCHEMBL8843374 | 0.87 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2RORBPDGFRBKDR | |
| SCHEMBL11002986 | 0.85 | ALDH1A1 (0.53) | ALDH1A1SMN1; SMN2RORBPDGFRBKDR | |
| SCHEMBL8843382 | 0.85 | ALDH1A1 (0.53) | ALDH1A1SMN1; SMN2RORBPDGFRBKDR | |
| SCHEMBL11002450 | 0.85 | RORB (0.49) | ALDH1A1SMN1; SMN2RORBPDGFRBKDR | |
| SCHEMBL11002573 | 0.84 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2RORBPDGFRBKDR | |
| SCHEMBL11003650 | 0.84 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2RORBPDGFRBKDR | |
| SCHEMBL11003587 | 0.84 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2RORBPDGFRBKDR | |
| SCHEMBL8842879 | 0.83 | MKNK1 (0.48) | ALDH1A1KDM4EKIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4706683-A2 | CHEWABLE FORMULATIONS | Elanco Tiergesundheit AG (CH) | 2026-03-11 | — | — | EP | disclosed |
| US-20230277448-A1 | CHEWABLE FORMULATIONS | ELANCO TIERGESUNDHEIT AG (CH) | 2023-09-07 | — | — | US | disclosed |
| EP-4208155-A1 | CHEWABLE FORMULATIONS | Elanco Tiergesundheit AG (CH) | 2023-07-12 | — | — | EP | disclosed |
| CN-115038451-A | Multimodal compositions and methods of treatment | 阿奎斯蒂弗医疗股份有限公司 | 2022-09-09 | — | — | CN | disclosed |
| WO-2022049149-A1 | CHEWABLE FORMULATIONS | ELANCO TIERGESUNDHEIT AG (CH) | 2022-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230277448-A1 | CHEWABLE FORMULATIONS | SI, TAS2R39, TAS2R31 | ALDH1A1 4640/4885SMN1; SMN2 1968/4885RORB 4407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.